Science Explorer Back to mapMap
Discussion
Institution · University Teaching Hospital

Most cited papers from University Teaching Hospital

University Teaching Hospital

What are the most cited papers from University Teaching Hospital?

The most cited paper from University Teaching Hospital is "Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study" (Ting Shi et al., 2017), with 2,491 citations. Next come "A living WHO guideline on drugs for covid-19 (2020-2023)" (1,096) and "Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study" (940).

Showing 50 of 60 papers. Every paper with more than 209 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study Ting Shi et al. · The Lancet ReviewOpen access122 authors 7 Jul 2017 2,491
2 A living WHO guideline on drugs for covid-19 (2020-2023) Arnav Agarwal et al. · BMJ Open access 4 Sep 2020 1,096
3 Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study Katherine L. O'Flynn O'Brien et al. · The Lancet Open access 27 Jun 2019 940
4 Tuberculosis Stephen D Lawn, Alimuddin I. Zumla · The Lancet 12 May 2011 761
5 ERS guidelines on the assessment of cough Alyn H. Morice, Giovanni A. Fontana, Maria Gabriela Belvisi et al. · European Respiratory Journal Open access 31 May 2007 711
6 Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease Danilo Fliser, Barbara Kollerits, Ulrich Neyer et al. · Journal of the American Society of Nephrology 26 Jul 2007 698
7 Global burden of postoperative death Dmitri Nepogodiev et al. · The Lancet Open access 31 Jan 2019 642
8 Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study Bruce McClure Biccard et al. · The Lancet Open access1,093 authors 3 Jan 2018 604
9 Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study) Liesl Joanna Zuhlke et al. · European Heart Journal Open access 25 Nov 2014 599
10 Sexual behavior of HIV discordant couples after HIV counseling and testing Susan A Allen, Jareen K. Meinzen‐Derr, Michele Kautzman et al. · AIDS Mar 2003 497
11 Malaria-related Anaemia Clara Menéndez, A. F. Fleming, Pedro Luis Alonso · Parasitology Today Nov 2000 470
12 Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test Stephen D Lawn, Peter Mwaba, Matthew Bates et al. · The Lancet Infectious Diseases Open access 24 Mar 2013 464
13 Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial Grant Theron, Lynn Sodai Zijenah, Duncan M Chanda et al. · The Lancet 28 Oct 2013 447
14 HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers Pam Sonnenberg, Jill Murray, Judith R. Glynn et al. · The Lancet Nov 2001 442
15 Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study Valentina Bellemo, Zhan Wei Lim, Gilbert Lim et al. · The Lancet Digital Health Open access May 2019 428
16 Newborn-Care Training and Perinatal Mortality in Developing Countries Waldemar A. Carlo, Shivaprasad S. Goudar, Imtiaz Jehan et al. · New England Journal of Medicine Open access 17 Feb 2010 424
17 Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria Xavier Montalbán et al. · The Lancet Neurology Open access 17 Sep 2025 420
18 Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa Síle F. Molloy et al. · New England Journal of Medicine Open access 14 Mar 2018 414
19 Host-directed therapies for infectious diseases: current status, recent progress, and future prospects Alimuddin I. Zumla, Martin Rao, Robert S. Wallis et al. · The Lancet Infectious Diseases Open access 21 Mar 2016 404
20 Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs Hervé Decousus, Paolo Prandoni, Patrick Mismetti et al. · New England Journal of Medicine Open access 22 Sep 2010 398
21 Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial Chifumbe Chintu, G.K. Bhat, AS Walker et al. · The Lancet Nov 2004 389
22 Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis Kathryn E. Lafond et al. · PLoS Medicine Open access 24 Mar 2016 381
23 Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial Matthew Hoffman et al. · The Lancet Open access 2020 374
24 Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer Dezheng Huo, Francis Ikpatt, Andrey Khramtsov et al. · Journal of Clinical Oncology Open access 25 Aug 2009 374
25 Rapid Spread of Zika Virus in The Americas - Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games Eskild Petersen, Mary Elizabeth Wilson, Sok Touch et al. · International Journal of Infectious Diseases Open access 4 Feb 2016 369
26 Tuberculosis: advances and challenges in development of new diagnostics and biomarkers Gerhard Walzl, Ruth McNerney, Nelita du Plessis et al. · The Lancet Infectious Diseases Open access 23 Mar 2018 366
27 Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa Ming Li et al. · Journal of Virology Open access 13 Nov 2006 365
28 Virologic and Immunologic Determinants of Heterosexual Transmission of Human Immunodeficiency Virus Type 1 in Africa U. Fideli, Susan A. Allen, Rosemary Mubanga Musonda et al. · AIDS Research and Human Retroviruses Open access 15 Jul 2001 363
29 A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial Fernando Althabe et al. · The Lancet Open access 15 Oct 2014 352
30 Scaling up interventions to achieve global tuberculosis control: progress and new developments Mario Carlo Raviglione, Ben J. Marais, Katherine Floyd et al. · The Lancet Open access May 2012 350
31 PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial Sheena McCormack et al. · The Lancet Open access 21 Sep 2010 336
32 Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study Chifumbe Chintu, Victor C. Mudenda, Sebastian B Lucas et al. · The Lancet Sep 2002 333
33 Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders F. M. Ross et al. · Haematologica Open access 27 Feb 2012 327
34 The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008 Abigail Fenwick, Joanne P. Webster, Elisa Bosqué‐Oliva et al. · Parasitology 27 Jul 2009 325
35 Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells Ann L. N. Chapman, Mwansa Munkanta, Katalin Andrea Wilkinson et al. · AIDS Nov 2002 320
36 Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts Ben J. Marais et al. · The Lancet Infectious Diseases Open access 24 Mar 2013 319
37 Effects of Early, Abrupt Weaning on HIV-free Survival of Children in Zambia Louise Kuhn, Grace M. Aldrovandi, Moses Sinkala et al. · New England Journal of Medicine Open access 4 Jun 2008 314
38 Priapism in sickle‐cell disease; incidence, risk factors and complications – an international multicentre study Adebanji Adeyoju, Adebayo Olujohungbe, James A. Morris et al. · British Journal of Urology Dec 2002 293
39 Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD Nicholas Alexander Kennedy et al. · Gut Open access 26 Apr 2021 281
40 Endometriosis: an inflammatory disease with a Th2 immune response component Sérgio Podgaec, Maurício Simões Abrão, João Dias et al. · Human Reproduction 18 Jan 2007 281
41 Adverse maternal and perinatal outcomes in adolescent pregnancies: The Global Network’s Maternal Newborn Health Registry study Fernando Althabe et al. · Reproductive Health Open access 8 Jun 2015 281
42 Drug-Induced Methaemoglobinaemia Treatment Issues Michael D. Coleman, Nicholas A. Coleman · Drug Safety Jun 1996 276
43 Drug-resistant tuberculosis: time for visionary political leadership Ibrahim Abubakar et al. · The Lancet Infectious Diseases Open access 24 Mar 2013 275
44 The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study Christian R. Laurent, Ndella Diakhaté, Ndèye Fatou Ngom Gueye et al. · AIDS Jul 2002 274
45 Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial Jonny Peter et al. · The Lancet Mar 2016 273
46 Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation Stuart J. Connolly et al. · New England Journal of Medicine Open access 28 Aug 2022 267
47 High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa For Yue Tso, Salum J. Lidenge, Phoebe B. Peña et al. · International Journal of Infectious Diseases Open access 8 Nov 2020 266
48 Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers Robert S. Wallis, Markus J. Maeurer, Peter Mwaba et al. · The Lancet Infectious Diseases Open access 22 Mar 2016 264
49 The Chinese University Of Hong Kong Key words, Hong Kong Med J, Prince Of Wales Hospital et al. · Computer May 2004 258
50 Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial Sayoki Mfinanga, Duncan M Chanda, Sokoine Lesikari Kivuyo et al. · The Lancet Open access 9 Mar 2015 256

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.